TFS CAPITAL LLC - ANTHERA PHARMACEUTICALS INC ownership

ANTHERA PHARMACEUTICALS INC's ticker is ANTH and the CUSIP is 03674U201. A total of 73 filers reported holding ANTHERA PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 1.31 and the average weighting 0.0%.

Quarter-by-quarter ownership
TFS CAPITAL LLC ownership history of ANTHERA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$13,000
-92.6%
19,945
-64.1%
0.00%
-92.9%
Q3 2016$175,000
+236.5%
55,622
+229.8%
0.04%
+320.0%
Q2 2016$52,000
-87.5%
16,867
-85.3%
0.01%
-83.3%
Q1 2016$415,000
+730.0%
114,610
+960.8%
0.06%
+1100.0%
Q4 2015$50,000
-91.6%
10,804
-84.3%
0.01%
-91.4%
Q2 2015$593,00068,7770.06%
Other shareholders
ANTHERA PHARMACEUTICALS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Abingworth LLP 861,723$1,174,0000.98%
R&F Capital Advisors LP 171,205$111,0000.04%
Rhenman & Partners Asset Management AB 200,000$130,0000.02%
Rock Springs Capital Management LP 380,000$247,0000.02%
WHITE PINE CAPITAL LLC 35,000$23,0000.01%
BVF INC/IL 62,292$40,0000.01%
Virtu KCG Holdings LLC 271,239$176,0000.00%
TURNER INVESTMENTS LLC 15,000$10,0000.00%
TWO SIGMA SECURITIES, LLC 11,736$8,0000.00%
Tower Research Capital LLC (TRC) 36,413$24,0000.00%
View complete list of ANTHERA PHARMACEUTICALS INC shareholders